REG - Yellow Cake PLC - RESULTS OF PLACING

Yellow CakeAnnouncement

12/02/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260212:nRSL7500Sa&default-theme=true

RNS Number : 7500S  Yellow Cake PLC  12 February 2026

12 February 2026

THIS ANNOUNCEMENT AND THE INFORMATION IN IT IS RESTRICTED AND IS NOT FOR
RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN
PART, IN, INTO OR WITHIN THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG,
SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE
A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF
SECURITIES IN ANY JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE
MARKET ABUSE REGULATION (EU) NO 596/2014 AS IT FORMS PART OF UK LAW BY VIRTUE
OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED ("MAR"). UPON THE
PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO
BE IN THE PUBLIC DOMAIN.

YELLOW CAKE PLC

RESULTS OF PLACING

Yellow Cake plc (AIM: YCA) ("Yellow Cake" or the "Company"), a specialist
company operating in the uranium sector founded by Bacchus Capital Advisers
("Bacchus Capital"), holding physical uranium ("U(3)O(8)") for the long term
and engaged in uranium-related commercial activities, is pleased to announce
that 12,818,760 new Ordinary Shares (the "Placing Shares") have been placed
with existing and new institutional investors at a fixed price of £6.29 per
share (the "Placing Price") via an accelerated bookbuild (the "Placing").

Due to strong investor demand, the Company agreed with the Joint Bookrunners
to increase the gross proceeds from the Placing to approximately US$110
million from the minimum of US$75 million originally proposed. Additional
proceeds are intended to be used to fund opportunistic and strategic purchases
of further U(3)O(8.)

The Placing of 12,818,760 new Ordinary Shares raised gross proceeds of
approximately US$110 million (equivalent to approximately £80.6 million). The
Placing Shares being issued represent approximately 5.3% of the existing
issued ordinary share capital (excluding treasury shares) of the Company prior
to the Placing. The Placing was conducted using the Company's existing share
authorities.

Andre Liebenberg, Chief Executive Officer of Yellow Cake, commented:

"We are pleased by the strong support shown by both new and existing
institutional investors in this placing. This raise enables us to fully
exercise our 2026 uranium purchase option under the Framework Agreement with
Kazatomprom, while retaining flexibility to pursue further strategic and
opportunistic purchases of physical uranium. The backdrop for uranium
continues to strengthen in our view. Supply remains tight, and structural
demand is accelerating through electrification and the substantial baseload
requirements of AI and hyperscale data centres. Increasing our physical
holdings at this point in the market strengthens our strategic position and
supports the continued delivery of long-term value for shareholders through
direct exposure to physical uranium."

Placing:

Application has been made for the Placing Shares to be admitted to trading on
the AIM market of London Stock Exchange plc ("AIM") ("Admission"). It is
expected that Admission will become effective at commencement of trading on 17
February 2026 and settlement is expected to take place on the same date on a
T+3 basis.

The Placing is conditional upon, inter alia, Admission becoming effective and
the Placing Agreement not being terminated in accordance with its terms.

Following Admission: (a) the total number of shares of the Company in issue
will be 257,243,467 of which 4,584,283 are held in treasury; and (b) the total
number of voting shares in the Company will be 252,659,184.

Other than where defined, capitalised terms used in this announcement have the
meanings given to them in the Announcement released by the Company at 17:29
p.m. (London time) on 11 February 2026.

Canaccord Genuity Limited ("Canaccord") and Joh. Berenberg, Gossler & Co.
KG, London Branch ("Berenberg") acted as joint bookrunners (together the
"Joint Bookrunners"). Bacchus Capital acted as Financial Adviser in connection
with the Placing.

 

ENQUIRIES:

 Yellow Cake plc
 Andre Liebenberg, CEO                    Carole Whittall, CFO
 Tel: +44 (0) 153 488 5200

 Joint Bookrunner, Nominated Adviser and Joint Broker: Canaccord Genuity
 Limited
 James Asensio                            Henry Fitzgerald-O'Connor
 Charlie Hammond
 Tel: +44 (0) 207 523 8000

 Joint Bookrunner and Joint Broker: Joh. Berenberg, Gossler & Co. KG,
 London Branch
 Matthew Armitt                           Jennifer Lee
 Detlir Elezi
 Tel: +44 (0) 203 207 7800

 Financial Adviser: Bacchus Capital Advisers
 Peter Bacchus                            Richard Allan
 Tel: +44 (0) 203 848 1640

 Communications Adviser: Sodali & Co
 Peter Ogden                              James Whitaker
 Tel: +44 (0) 7793 858 211

ABOUT YELLOW CAKE

Yellow Cake is a London-quoted company, incorporated in Jersey, which offers
exposure to the uranium spot price. This is achieved through its strategy of
buying and holding U(3)O(8). It may also seek to add value through other
uranium-related activities. Yellow Cake and its wholly owned subsidiary (the
"Group") seek to generate returns for shareholders through the appreciation of
the value of its holding of U(3)O(8) and its other uranium-related activities
in a rising uranium price environment. The business is differentiated from its
peers by its ten-year Framework Agreement for the supply of U(3)O(8) with
Kazatomprom, the world's largest uranium producer. The Group currently holds
21.68 million pounds of U(3)O(8), all of which is held in storage in Canada
and France.

The information contained within this Announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
(EU) No 596/2014 as it forms part of UK law by virtue of the European Union
(Withdrawal) Act 2018, as amended. By the publication of this Announcement via
a Regulatory Information Service, this inside information is now considered to
be in the public domain. The person responsible for arranging for the release
of this Announcement on behalf of the Company is Andre Liebenberg.

IMPORTANT NOTICES

This Announcement (the "Announcement") and the information in it is restricted
and is not for release, publication or distribution, directly or indirectly,
in whole or in part, in, into or within the United States of America its
territories and possessions, any state of the United States or the District of
Columbia (collectively, the "United States"), Canada, Australia, Hong Kong,
South Africa or Japan or any other jurisdiction where to do so might
constitute a violation of the relevant laws or regulations of such
jurisdiction (each a "Restricted Territory"). This announcement does not
constitute an offer to sell or issue or the solicitation of an offer to buy or
acquire for placing shares in any Restricted Territory. Any failure to comply
with these restrictions may constitute a violation of the securities laws of
such jurisdictions. Subject to certain exemptions, the securities referred to
in this Announcement may not be offered or sold in any Restricted Territory or
for the account or benefit of any national resident or citizen of any
Restricted Territory. This Announcement has not been approved by the London
Stock Exchange, nor is it intended that it will be so approved.

In particular the securities referred to herein have not been and will not be
registered under the U.S. Securities Act of 1933 (the "Securities Act"), or
with any securities regulatory authority of any state or other jurisdiction of
the United States, and may not be offered, sold, pledged, taken up, exercised,
resold, renounced, transferred or delivered, directly or indirectly, in the
United States absent registration under the Securities Act, except pursuant to
an exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act and in compliance with any applicable
securities laws of any state or other jurisdiction of the United States. The
securities referred to herein are being offered and sold only: (i) to non-U.S.
persons outside the United States in "offshore transactions" pursuant to
Regulation S of the Securities Act and (ii) inside the United States to
"qualified institutional buyers" as defined in Rule 144A under the Securities
Act who have duly executed a U.S. investor letter in the form provided to it
and delivered the same to the Company, the Joint Bookrunners or their
affiliates.

The offer and sale of the Placing Shares referred to herein has not been and
will not be registered under the applicable securities laws of any Restricted
Territory.

No public offering of the shares referred to in this Announcement is being
made in the United States, the United Kingdom, any Restricted Territory or
elsewhere.

The securities referred to herein have not been approved or disapproved by the
U.S. Securities and Exchange Commission, any state securities commission or
other regulatory authority in the United States nor have any of the foregoing
authorities passed upon or endorsed the merits of the offering of the
securities referred to herein or the accuracy or adequacy of this
Announcement. Any representation to the contrary is a criminal offence in the
United States.

The Company has not been, and will not be, registered under the U.S.
Investment Company Act of 1940 and investors will not be entitled to the
benefits of that Act. All offers of Placing Shares will be made pursuant to an
exemption from the requirement to produce a prospectus under the Prospectus
Regulation (Regulation (EU) 2017/1129) (the "Prospectus Regulation") in
relevant member states of the European Economic Area ("EEA") and under the
Public Offers and Admissions to Trading Regulations 2024, as amended (the
"POATR"), in the United Kingdom. Members of the public are not eligible to
take part in the Placing.

This Announcement and the information contained herein are for information
purposes only and are directed only at: (a) persons in Member States of the
EEA who are qualified investors within the meaning of article 2(e) of the
Prospectus Regulation; (b) in the United Kingdom, "qualified investors" within
the meaning of paragraph 15 of Schedule 1 of the POATR who (i) are "Investment
Professionals" specified in article 19(5) of the Financial Services and
Markets Act (Financial Promotion) Order 2005, as amended (the "Order") or (ii)
fall within article 49(2)(a) to (d) of the Order (and only where the
conditions contained in those articles have been, or will at the relevant time
be, satisfied); (c) persons that are residents of Canada or otherwise subject
to the securities laws of Canada which are ''permitted clients'' as defined in
National Instrument 31 - 103 - Registration Requirements, Exemptions and
Ongoing Registrant Obligations; (d) in Australia, are sophisticated investors
or professional investors as those terms are defined in sub- sections 708(8)
and 708(11) of the Corporations Act; (e) in Hong Kong, are professional
investors as defined in the Securities and Futures Ordinance (Cap 571) of Hong
Kong and any rules made under that Ordinance; or (f) are persons to whom it
may otherwise be lawfully communicated (all such persons together being
referred to as "Relevant Persons"). This Announcement does not itself
constitute an offer for sale or to acquire any securities in the Company. This
Announcement must not be acted on or relied on by persons who are not Relevant
Persons. Any investment or investment activity to which this Announcement
relates is available only to Relevant Persons and will be engaged in only with
Relevant Persons. Each Placee should consult with its own advisers as to
legal, tax, business and related aspects of an investment in Placing Shares.

Solely for the purposes of the product governance requirements of Chapter 3 of
the FCA Handbook Product Intervention and Product Governance Sourcebook (the
"UK Product Governance Requirements"), and disclaiming all and any liability,
whether arising in tort, contract or otherwise, which any "manufacturer" (for
the purposes of the UK Product Governance Requirements) may otherwise have
with respect thereto, the Shares have been subject to a product approval
process, which has determined that the Placing Shares are: (i) compatible with
an end target market of retail investors and investors who meet the criteria
of professional clients and eligible counterparties, each defined in paragraph
3 of the FCA Handbook Conduct of Business Sourcebook; and (ii) eligible for
distribution through all permitted distribution channels to professional
clients and eligible counterparties (the "Target Market Assessment").

Notwithstanding the Target Market Assessment for the Placing Shares,
distributors should note that: the price of the Placing Shares may decline and
investors could lose all or part of their investment; the Placing Shares offer
no guaranteed income and no capital protection; and an investment in the
Placing Shares is compatible only with investors who do not need a guaranteed
income or capital protection, who (either alone or in conjunction with an
appropriate financial or other adviser) are capable of evaluating the merits
and risks of such an investment and who have sufficient resources to be able
to bear any losses that may result therefrom.

The Target Market Assessment is without prejudice to the requirements of any
contractual, legal or regulatory selling restrictions in relation to the
offering of the Placing Shares. Furthermore, it is noted that, notwithstanding
the Target Market Assessment, the Joint Bookrunners will only procure
investors who meet the criteria of professional clients and eligible
counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute:
(a) an assessment of suitability or appropriateness for the purposes of the UK
Product Governance Requirements; or (b) a recommendation to any investor or
group of investors to invest in, or purchase, or take any other action
whatsoever with respect to the Placing Shares.

Each distributor is responsible for undertaking its own target market
assessment in respect of the Placing Shares and determining appropriate
distribution channels.

No representation or warranty, express or implied, is made or given by or on
behalf of the Company, the Joint Bookrunners, the Company's nominated adviser,
or any of their respective affiliates (within the meaning of Rule 405 under
the Securities Act) ("Affiliates") or any of such persons' directors,
partners, officers or employees or any other person as to the accuracy,
completeness or fairness of the information or opinions contained in this
Announcement and no liability whatsoever is accepted by the Company, the
 Joint Bookrunners or any of such persons' Affiliates, partners, directors,
officers or employees or any other person for any loss howsoever arising,
directly or indirectly, from any use of such information or opinions or
otherwise arising in connection therewith.

Canaccord is authorised and regulated by the Financial Conduct Authority
("FCA"). Berenberg is authorised and regulated by the German Federal Financial
Supervisory Authority and in the United Kingdom is authorised and regulated by
the FCA. Each of the Joint Bookrunners are acting exclusively for the Company
and no one else in connection with the Placing and they will not be
responsible to anyone other than the Company for providing the protections
afforded to their respective clients nor for providing advice in relation to
the Placing and/or any other matter referred to in this Announcement.

This Announcement is being issued by and is the sole responsibility of the
Company. No representation or warranty, express or implied, is or will be made
as to, or in relation to, and no responsibility or liability is or will be
accepted by the  Joint Bookrunners (apart from the responsibilities or
liabilities that may be imposed by the FSMA or the regulatory regime
established thereunder) or by any of their respective affiliates or agents or
by any of their respective directors, partners, officers, employees, advisers,
representatives or shareholders (collectively, "Representatives") for the
contents of the information contained in this Announcement, or any other
written or oral information made available to or publicly available to any
interested party or its advisers, or any other statement made or purported to
be made by or on behalf of the Joint Bookrunners or any of their respective
affiliates or by any of their respective Representatives in connection with
the Company, the Placing Shares or the Placing and any responsibility and
liability whether arising in tort, contract or otherwise therefore is
expressly disclaimed. Each of the Joint Bookrunners and each of their
respective affiliates accordingly disclaim all and any liability, whether
arising in tort, contract or otherwise (save as referred to above) in respect
of any statements or other information contained in this Announcement and no
representation or warranty, express or implied, is made by the Joint
Bookrunners or any of their respective affiliates as to the accuracy,
fairness, verification, completeness or sufficiency of the information
contained in this Announcement and nothing in this Announcement is, or shall
be relied upon as, a promise or representation in this respect, whether as to
the past or future. This Announcement does not identify or suggest, or purport
to identify or suggest, the risks (direct or indirect) that may be associated
with an investment in the Placing Shares. Any investment decision to buy
Placing Shares in the Placing must be made solely on the basis of publicly
available information, which has not been independently verified by the Joint
Bookrunners. Shares will not be admitted on any stock exchange other than AIM.

The distribution of this Announcement and the offering of the Placing Shares
in certain jurisdictions may be restricted by law. Persons distributing any
part of this Announcement must satisfy themselves that it is lawful to do so.
Persons (including, without limitation, nominees and trustees) who have a
contractual or other legal obligation to forward a copy of this Announcement
should seek appropriate advice before taking any action. Any failure to comply
with these restrictions may constitute a violation of the securities laws of
such jurisdictions. Persons into whose possession this Announcement comes are
required by the Joint Bookrunners and the Company to inform themselves about,
and observe, any such restrictions.

Neither the content of the Company's website nor any website accessible by
hyperlinks on the Company's website is incorporated in, or forms part of, this
Announcement.

This Announcement contains "forward-looking statements". Forward-looking
statements sometimes use words such as "aim", "anticipate", "target",
"expect", "estimate", "intend", "plan", "goal", "believe", "seek", "may",
"could", "outlook" or other words of similar meaning. By their nature, all
forward-looking statements involve risk and uncertainty because they relate to
future events and circumstances which are beyond the control of the Company.
Any forward-looking statements made in this Announcement by or on behalf of
the Company speak only as of the date they are made. Statements contained in
this Announcement regarding past trends or activities should not be taken as
representation that such trends or activities will continue in the future. You
should not place undue reliance on forward-looking statements, which speak
only as of the date of this Announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROISFUSMEEMSEDE



            Copyright 2019 Regulatory News Service, all rights reserved